Craig Crews Awarded the 2020 Heinrich Wieland Prize
October 14, 2020
Thanks to the results of his many years of research, Professor Craig M. Crews is making innovative new medicines possible. So-called PROTACs (proteolysis-targeting chimeras) activate a cell’s quality control system to target disease-causing proteins for degradation. These new active substances are intended to specifically destroy proteins that, until now, have been therapeutically impervious. For his ground-breaking research, Professor Crews has been awarded the 2020 Heinrich Wieland Prize.